Rare Disease Issues.
2025 · 1st Quarter (Jan 1 - Mar 31)
TAKEDA PHARMACEUTICALS AMERICA, INC.
Filed by TODD STRATEGY GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 21, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- TODD STRATEGY GROUP
- Filing UUID
- 7c4d1ac3-1476-4b70-84a1-bc65ec208f9f
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
General Medicare/Medicaid Issues. Implementation of Inflation Reduction Act of 2022.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.